Navigation Links
Boehringer Ingelheim Pharmaceuticals, Inc. Statement on RE-ALIGN Data
Date:8/31/2013

RIDGEFIELD, Conn., Sept. 1, 2013 /PRNewswire/ -- Today, data from the RE-ALIGN™ trial of dabigatran etexilate mesylate in patients with mechanical prosthetic heart valves were presented at the European Society of Cardiology (ESC) congress in Amsterdam, Netherlands, and published online in the New England Journal of Medicine. As part of Boehringer Ingelheim Pharmaceuticals, Inc.'s ongoing commitment to transparency, we previously announced on December 11, 2012, that this trial had been discontinued based on interim results which showed an increased incidence of thromboembolic and bleeding events in patients treated with dabigatran compared to warfarin. The RE-ALIGN study did not enroll any U.S. patients.

On December 19, 2012, the U.S. prescribing information for Pradaxa® (dabigatran etexilate mesylate) capsules was updated to include a contraindication, as well as a warning and precaution related to its use in patients with prosthetic heart valves. At that time, Boehringer Ingelheim instructed all investigators in the RE-ALIGN trial to switch patients treated with dabigatran in the study to warfarin. In addition, Boehringer Ingelheim sent letters to healthcare professionals in the U.S. informing them of the contraindication in the updated U.S. label.

"RE-ALIGN was the first, and remains the only, randomized study performed comparing a new oral anticoagulant with warfarin in patients with mechanical prosthetic heart valves. Our commitment to studying populations with unmet needs, such as those with mechanical prosthetic heart valves, serves to expand the body of knowledge around this novel compound and this patient population," said Sabine Luik, M.D., senior vice president, Medicine & Regulatory Affairs, U.S. Regional Medical Director, Boehringer Ingelheim Pharmaceuticals, Inc. "We are confident in the safety and efficacy of dabigatran when used as directed to reduce the
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
2. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
3. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
4. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
5. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
8. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
9. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
10. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
11. Boehringer Ingelheim Announces Equine Research Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 04, 2015 Research ... addition of the "MRI Systems Market to ... Efficiency, with Growth Driven by Developing Economies" ... Market to 2020 - Focus on Patient Comfort ... Economies" discusses the market, competitive landscape, and trends ...
(Date:8/4/2015)... and LOS ANGELES , Aug. ... DGX ), the world,s leading provider of diagnostic ... the previously announced acquisition of MemorialCare Health System,s ... a result of the transaction, patients and physicians ... innovative services and network of nearly 200 patient ...
(Date:8/4/2015)... Pharma, Inc. (Nasdaq: MEIP ), an oncology company focused ... today that Daniel P. Gold , Ph.D., President and ... Healthcare Conference on Tuesday, August 11, 2015 at 3:40 p.m. ... New York . A live webcast of the ... will be available approximately one hour after the presentation. ...
Breaking Medicine Technology:Global MRI Systems Market Outlook to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies 2Quest Diagnostics Completes Acquisition of MemorialCare Health System's Laboratory Outreach Service Business in Southern California 2MEI Pharma to Present at Wedbush PacGrow Healthcare Conference 2
... Sosei Group Corporation,("Sosei"; TSE Mothers Index: 4565), ... Japanese Phase III clinical trial for the,emergency contraceptive ... rights to the product in Japan from HRA ... evaluate the safety and prevented,pregnancy rate of SOH-075 ...
... Americans, WASHINGTON, July 9 In a congressional,hearing ... the,safety and importance of the research programs operated by ... absolute commitment to its patients,while expressing regret that even ... "VA has an outstanding research program, and has been ...
Cached Medicine Technology:Sosei Announces Completion of Phase III Trial for NorLevo(R) 2Secretary Reinforces VA's Commitment to Research Safety and Veteran Focus 2Secretary Reinforces VA's Commitment to Research Safety and Veteran Focus 3
(Date:8/4/2015)... ... August 04, 2015 , ... How cool is it to check in at ... The new "Now" feature will soon allow you to do just that. , Ahhaa ... other using the now feature. , Users will soon get to share what inspires ...
(Date:8/4/2015)... ... 2015 , ... World Patent Marketing, a vertically integrated manufacturer ... invention that eliminates the need to have a partner or trainer when using ... worth $30 billion," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:8/4/2015)... WASHINGTON, D.C. (PRWEB) , ... August 04, 2015 ... ... issues fellowship focused on sexual and reproductive health and rights in Indonesia for ... Journalists will visit a number of sites in Indonesia and attend the International ...
(Date:8/4/2015)... CA (PRWEB) , ... August 04, 2015 , ... An ... that found financial incentives to be a viable method for encouraging people to lose ... money on the future of their weight loss success, adding a financial incentive to ...
(Date:8/4/2015)... CA (PRWEB) , ... August 04, 2015 , ... ... are suffering from underarm sweat. Evolutions Medical & Day Spa in Santa Barbara, ... the only non-invasive, FDA cleared treatment that permanently eliminates sweat and odor glands ...
Breaking Medicine News(10 mins):Health News:Ahhaa App Soon to Release the "Now" Feature 2Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 2Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 3Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 4Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 5Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 6Health News:UN Foundation Announces Press Fellowship to Indonesia with Focus on Women’s Health and Rights 2Health News:Article on Incentivizing Weight Loss Mirrors Similar Motivations Surrounding Weight Loss Surgery, Says Dr. Feiz & Associates 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 3
... , , VOORHEES, N.J., Sept. ... involving the skin, visceral organs, and airway, causing discomfort and even ... of therapies available for the prevention and treatment of angioedema, and ... acute attacks on this patient population. , , ...
... Calls on Congress to Enact Reform , ... Liability and Access today commended President Obama for acknowledging the need ... Congress to follow the President,s leadership by including reform in pending ... an address to Congress, President Obama said, "I,ve talked to enough ...
... , , , ... announced today that it has established the Edward Neurosciences Institute ... the highest level of stroke care in the world to ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090910/CG73991 ) , , ...
... , , GREEN ... to keep a strong, healthy immune system. That means getting enough ... there are body stressors you can,t avoid. Environmental toxins are all ... The effects of these toxins can result in a toxic burden ...
... , , NEW BRUNSWICK, ... New York Giants vs. Washington Redskins game this Sunday, September ... new fight: supporting PSE&G Children,s Specialized Hospital, an inpatient rehabilitation ... life-changing conditions. , , Through an ...
... , ... of Cosmetic Injectables Can be a Felony , ... New York, NY (Vocus) September 10, 2009 -- One year in prison ... cosmetic injectables. As recently as August 2009, five physicians, one nurse and a practice ...
Cached Medicine News:Health News:New Directions in Angioedema: A Focus on Supportive Care and Treatment Options 2Health News:Broad Health Coalition Applauds President Obama's Commitment to Medical Liability Reform 2Health News:Edward Announces New Neurosciences Institute in Partnership With Northwestern Medical Faculty Foundation 2Health News:Edward Announces New Neurosciences Institute in Partnership With Northwestern Medical Faculty Foundation 3Health News:The #1 Stay Healthy Secret - Whole Body Cleanse(TM) from Enzymatic Therapy 2Health News:PSE&G Children's Specialized Hospital and New York Giants Team Up to Offer Text to Donate Campaign 2Health News:Physicians Coalition for Injectable Safety Urges Reporting of Suspected Illegal Solicitation or Use of Botox, Restylane, Radiesse and Others 2Health News:Physicians Coalition for Injectable Safety Urges Reporting of Suspected Illegal Solicitation or Use of Botox, Restylane, Radiesse and Others 3
A simple solution to hand assisted laparoscopic surgery....
... The HandPort Systems non-adhesive ... during Hand-Assisted Laparoscopic Surgrery (HALS) ... touch, grasp, and palpate throughout. ... small as 6 cm, patients ...
... 200 series offers a range of ... The design delivers therapy to meet ... promote results in commercial and clinical ... differentiator in the SleepStyle 200 series ...
The SleepStyle 600 series with ThermoSmart delivers humidification with anti-rainout benefits. ThermoSmart technology offers a heated breathing tube that allows the constant delivery of optimal level...
Medicine Products: